Depletion of intracellular glutathione increases susceptibility to nitric oxide in mesencephalic dopaminergic neurons

Journal of Neurochemistry

Volumn 73, Issue 4, 1999, Pages 1696-1703

  Ibi, Masakazu ^a   Sawada, Hideyuki ^a   Kume, Toshiaki ^a   Katsuki, Hiroshi ^a   Kaneko, Shuji ^a   Shimohama, Shun ^a   Akaike, Akinori ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Dopaminergic neuron; Glutamate; Glutathione; Iron; Nitric oxide

Indexed keywords

ACETYLCYSTEINE; BUTHIONINE SULFOXIMINE; DEFEROXAMINE; GLUTAMIC ACID; GLUTATHIONE; GLUTATHIONE SYNTHASE; IRON; NITRIC OXIDE;

ANIMAL CELL; ARTICLE; CELL LEVEL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; FETUS; GLUTATHIONE METABOLISM; INCUBATION TIME; MESENCEPHALON; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BUTHIONINE SULFOXIMINE; CELLS, CULTURED; DEFEROXAMINE; DOPAMINE; FETUS; GLUTAMIC ACID; GLUTATHIONE; MESENCEPHALON; NEURONS; NEUROTOXINS; NITRIC OXIDE DONORS; NITROSO COMPOUNDS; RATS;

EID: 0032877449     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.731696.x     Document Type: Article

References (43)

1. Akaike A., Tamura Y., Terada K., and Nakata N. (1994) Regulation by neuroprotective factors of NMDA receptor mediated nitric oxide synthesis in the brain and retina. Prog. Brain Res. 103, 391-403.
2. Ambani L. M., Van Woert M. H., and Murphy S. (1975) Brain peroxidase and catalase in Parkinson's disease. Arch. Neurol. 32, 114-118.
3. Bayne K. (1996) Revised guide for the care and use of laboratory animals available. Physiologist 39, 199-208.
4. Beinert H. and Kennedy M. C. (1993) Aconitase, a two-faced protein: enzyme and iron regulatory factor. FASEB J. 7, 1442-1449.
5. Ben-Shachar D., Riederer P., and Youdim M. B. (1991) Iron-melanin interaction and lipid peroxidation: implications for Parkinson's disease. J. Neurochem. 57, 1609-1614.
6. Benzi G. and Moretti A. (1995) Age-and peroxidative stress-related modifications of the cerebral enzymatic activities linked to mitochondria and the glutathione system. Free Radic. Biol. Med. 19, 77-101.
7. Blandini F., Porter R. H., and Greenamyre J. T. (1996) Glutamate and Parkinson's disease. Mol. Neurobiol. 12, 73-94.
8. Bliss T. and Collingridge G. L. (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361, 31-39.
9. Bredt D. S. and Snyder S. H. (1989) Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc. Natl. Acad. Sci. USA 86, 9030-9033.
10. Cohen G. (1990) Monoamine oxidase and oxidative stress as dopaminergic synapses. J. Neural Transm. Suppl. 32, 229-238.
11. Collingridge G. and Singer W. (1990) Excitatory amino acid receptors and synaptic plasticity. Trends Pharmacol. Sci. 11, 290-296.
12. Dawson V. L., Dawson T. M., London E. D., Bredt D. S., and Snyder S. H. (1991) Nitric oxide mediates glutamate neurotoxicity in primary cortical culture. Proc. Natl. Acad. Sci. USA 88, 6368-6371.
13. Dawson V. L., Dawson T. M., Bartley D. A., Uhl G. R., and Snyder S. H. (1993) Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J. Neurosci. 13, 2651-2661.
14. Dexter D. T., Carayon A., Javoy-Agid F., Agid Y., Wells F. R., Daniel S. E., Lees A. J., Jenner P., and Marsden C. D. (1991) Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 114, 1953-1975.
15. Drapier J. C. and Hibbs J. B. Jr. (1986) Murine cytotoxic activated macrophages inhibit aconitase in tumor cells. Inhibition involves the iron-sulfur prosthetic group and is reversible. J. Clin. Invest. 78, 790-797.
16. Drapier J. C., Hirling H., Wietzerbin J., Kaldy P., and Kuhn L. C. (1993) Biosynthesis of nitric oxide activates iron regulatory factor in macrophages. EMBO J. 12, 3643-3649.
17. Gonzalez-Zulueta M., Ensz L. M., Mukhina G., Lebovitz R. M., Zwacka R. M., Engelhardt J. F., Oberley L. W., Dawson V. L., and Dawson T. M. (1998) Manganese superoxide dismutase protects nNOS neurons from NMDA and nitric oxide-mediated neurotoxicity. J. Neurosci. 18, 2040-2055.
18. Graham D. G. (1978) Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol. Pharmacol. 14, 633-643.
19. Hou J.-G. G., Cohen G., and Mytilineou C. (1997) Basic fibroblast growth factor stimulation of glial cells protects dopamine neurons from 6-hydroxydopamine toxicity: involvement of the glutathione system. J. Neurochem. 69, 76-83.
20. Jenner P. and Olanow C. W. (1996) Oxidative stress and the pathogenesis of Parkinson's disease. Neurology 47 (Suppl. 3), S161-S170.
21. Kim Y. M., de Vera M. E., Watkins S. C., and Billiar T. R. (1997) Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor-α-induced apoptosis by inducing heat shock protein 70 expression. J. Biol. Chem. 272, 1402-1411.
22. Klausner R. D., Rouault T. A., and Harford J. B. (1993) Regulating the fate of mRNA: the control of cellular iron metabolism. Cell 72, 19-28.
23. Konorev E. A., Tarpey M. M., Joseph J., Baker J. E., and Kalyanaraman B. (1995) S-Nitrosoglutathione improves functional recovery in the isolated rat heart after cardioplegic ischemic arrest - evidence for a cardioprotective effect of nitric oxide. J. Pharmacol. Exp. Ther. 274, 200-206.
24. 35S]glutathione binding sites in spinal cords from patients with amyotrophic lateral sclerosis. Neurosci. Lett. 163, 89-92.
25. Li Y., Maher P., and Schubert D. (1997a) A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion. Neuron 19, 453-463.
26. Li Y., Maher P., and Schubert D. (1997b) Requirement for cGMP in nerve cell death caused by glutathione depletion. J. Cell Biol. 139, 1317-1324.
27. Liu B. and Hannun Y. A. (1997) Inhibition of the neutral magnesium-dependent sphingomyelinase by glutathione. J. Biol. Chem. 272, 16281-16287.
28. Nakamura K., Wang W., and Kang U. J. (1997) The role of glutathione in dopaminergic neuronal survival. J. Neurochem. 69, 1850-1858.
29. Pantopoulos K. and Hentze M. W. (1995) Nitric oxide signaling to iron-regulatory protein: direct control of ferrilin mRNA translation and transferrin receptor mRNA stability in transfected fibroblasts. Proc. Natl. Acad. Sci. USA 92, 1267-1271.
30. Perry T. M. and Young W. W. (1986) Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients. Neurosci. Lett. 67, 269-274.
31. Pileblad E., Magnusson T., and Fornstedt B. (1989) Reduction of brain glutathione by L-buthionine sulfoximine potentiates the dopamine-depleting action of 6-hydroxydopamine in rat striatum. J. Neurochem. 52, 978-980.
32. Przedborski S., Jackson-Lewis V., Yokoyama R., Shibata T., Dawson V. L., and Dawson T. M. (1996) Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc. Natl. Acad. Sci. USA 93, 4565-4571.
33. Rauhala P., Mohanakumar K. P., Sziraki I., Lin A. M., and Chiueh C. C. (1996) S-Nitrosothiols and nitric oxide, but not sodium nitroprusside, protect nigrostriatal dopamine neurons against iron-induced oxidative stress in vivo. Synapse 23, 58-60.
34. Rauhala P., Lin A. M., and Chiueh C. C. (1998) Neurotprotection by S-nitrosoglutathione of brain dopamine neurons from oxidative stress. FASEB J. 12, 165-173.
35. Sawada H., Kawamura T., Shimohama S., Akaike A., and Kimura J. (1996a) Different mechanisms of glutamate-induced neuronal death between dopaminergic and nondopaminergic neurons in rat mesencephalic culture. J. Neurosci. Res. 43, 503-510.
36. Sawada H., Shimohama S., Kawamura T., Akaike A., Kitamura Y., Taniguchi T., and Kimura J. (1996b) Mechanism of resistance to NO-induced neurotoxicity in cultured rat mesencephalic neurons. J. Neurosci. Res. 46, 509-518.
37. Sian J., Dexter D. T., Lees A. J., Daniel S., Agid Y., Javoy-Agid F., Jenner P., and Marsden C. D. (1994) Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann. Neurol. 36, 348-355.
38. Spina M. B., Squinto S. P., Miller J., Lindsay R. M., and Hyman C. (1992) Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system. J. Neurochem. 59, 99-106.
39. Stadler J., Billiar T. R., Curran R. D., Stuehr D. J., Ochoa J. B., and Simmons R. L. (1991) Effect of exogenous and endogenous nitric oxide on mitochondrial respiration of rat hepatocytes. Am. J. Physiol. 260, C910-C916.
40. Struck A. T., Hogg N., Thomas J. P., and Kalyanaraman B. (1995) Nitric oxide donor compounds inhibit the toxicity of oxidized low-density lipoprotein to endothelial cells. FEBS Lett. 361, 291-294.
41. Toffa S., Kunikowska G. M., Zeng B. Y., Jenner P., and Marsden C. D. (1997) Glutathione depletion in rat brain does not cause nigrostriatal pathway degeneration. J. Neural Transm. 104, 67-75.
42. + toxicity in nigral dopaminergic neurones. Neuroreport 7, 921-923.
43. Zhang P., Damier P., Hirsch E. C., Agid Y., Ceballos-Picot I., Sinet P. M., Nicole A., Laurent M., and Javoy-Agid F. (1993) Preferential expression of superoxide dismutase messenger RNA in melanized neurons in human mesencephalon. Neuroscience 55, 167-175.